Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 359-363

  Dominguez Rodriguez, Alberto ^a,b   Abreu Gonzalez, Pedro ^c   Piccolo, Raffaele ^d   Galasso, Gennaro ^e   Reiter, R J ^f  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF SALERNO   (Italy)

^f Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Cardiac resynchronization therapy; Heart failure; Melatonin; Reverse remodeling

Indexed keywords

MELATONIN;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PARAMETERS; CIRCADIAN RHYTHM; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR REVERSE REMODELING; MAJOR CLINICAL STUDY; MALE; MULTICENTER AUTOMATIC DEFIBRILLATOR IMPLANTATION TRIAL WITH CARDIAC RESYNCHRONIZATION THERAPY SCORE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSSYNCHRONY; ADVERSE EFFECTS; AGED; BLOOD; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MELATONIN; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84977663947     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.056     Document Type: Article

References (29)

1. [1] St John Sutton, M., Ghio, S., Plappert, T., Tavazzi, L., Scelsi, L., Daubert, C., Abraham, W.T., Gold, M.R., Hassager, C., Herre, J.M., Linde, C., REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation 120 (2009), 1858–1865.
2. [2] Díaz-Infante, E., Mont, L., Leal, J., García-Bolao, I., Fernández-Lozano, I., Hernández-Madrid, A., Pérez-Castellano, N., Sitges, M., Pavón-Jiménez, R., Barba, J., Cavero, M.A., Moya, J.L., Pérez-Isla, L., Brugada J; SCARS investigators. Predictors of lack of response to resynchronization therapy. Am. J. Cardiol. 95 (2005), 1436–1440.
3. [3] Chung, E.S., Leon, A.R., Tavazzi, L., Sun, J.P., Nihoyannopoulos, P., Merlino, J., Abraham, W.T., Ghio, S., Leclercq, C., Bax, J.J., Yu, C.M., Gorcsan, J. III, St John Sutton, M., De Sutter, J., Murillo, J., Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117 (2008), 2608–2616.
4. [4] Braunwald, E., Biomarkers in heart failure. N. Engl. J. Med. 358 (2008), 2148–2159.
5. [5] Fertin, M., Dubois, E., Belliard, A., Amouyel, P., Pinet, F., Bauters, C., Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. Am. J. Cardiol. 110 (2012), 277–283.
6. [6] Motiwala, S.R., Szymonifka, J., Belcher, A., Weiner, R.B., Baggish, A.L., Sluss, P., Gaggin, H.K., Bhardwaj, A., Januzzi, J.L., Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur. J. Heart Fail. 15 (2013), 1157–1163.
7. [7] Weiner, R.B., Baggish, A.L., Chen-Tournoux, A., Marshall, J.E., Gaggin, H.K., Bhardwaj, A., Mohammed, A.A., Rehman, S.U., Barajas, L., Barajas, J., Gregory, S.A., Moore, S.A., Semigran, M.J., Januzzi, J.L. Jr., Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. Eur. J. Heart Fail. 15 (2013), 342–351.
8. [8] Ravassa, S., García-Bolao, I., Zudaire, A., Macías, A., Gavira, J.J., Beaumont, J., Arias, T., Huerta, A., Díez, J., Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. Cardiovasc. Res. 88 (2010), 304–313.
9. [9] Kortekaas, K.A., Hoogslag, G.E., de Boer, R.A., Dokter, M.M., Versteegh, M.I., Braun, J., Marsan, N.A., Verwey, H.F., Delgado, V., Schalij, M.J., Klautz, R.J., Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair. Eur. J. Heart Fail. 15 (2013), 1011–1018.
10. [10] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Sanchez-Sanchez, J.J., Kaski, J.C., Reiter, R.J., Melatonin and circadian biology in human cardiovascular disease. J. Pineal Res. 49 (2010), 14–22.
11. [11] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Reiter, R.J., The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy. Int. J. Cardiol. 174 (2014), 415–417.
12. [12] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Arroyo-Ucar, E., Avanzas, P., Reiter, R.J., Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: a two-dimensional speckle tracking study. Biomarkers 18 (2013), 310–313.
13. [13] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Avanzas, P., The role of melatonin in acute myocardial infarction. Front. Biosci. (Landmark Ed.) 17 (2012), 2433–2441.
14. [14] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Jimenez-Sosa, A., Avanzas, P., Bosa-Ojeda, F., Kaski, J.C., Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am. J. Cardiol. 106 (2010), 1540–1544.
15. [15] Yueng, H.M., Hung, M.W., Lau, C.F., Fung, M.L., Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J. Pineal Res. 58 (2015), 12–25.
16. [16] Yang, Y., Sun, Y., Yi, W., Li, Y., Fan, C., Xin, Z., Jiang, S., Di, S., Qu, Y., Reiter, R.J., Yi, D., A review of melatoninas a suitable antioxidant against ischemia–reperfusion injury and clinical heart diseases. J. Pineal Res. 57 (2014), 357–366.
17. [17] Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Arroyo-Ucar, E., Reiter, R.J., Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J. Pineal Res. 53 (2012), 319–323.
18. [18] Simko, F., Reiter, R.J., Pechanova, O., Paulis, L., Experimental models of melatonin-deficient hypertension. Front. Biosci. (Landmark Ed.) 18 (2013), 616–625.
19. [19] Hu, W., Ma, Z., Jiang, S., Fan, C., Deng, C., Yan, X., Di, S., Lv, J., Reiter, R.J., Yang, Y., Melatonin; the dawning of a treatment for fibrosis. J. Pineal Res. 60 (2016), 121–131.
20. [20] Bleeker, G.B., Bax, J.J., Fung, J.W., van der Wall, E.E., Zhang, Q., Schalij, M.J., Chan, J.Y., Yu, C.M., Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am. J. Cardiol. 97 (2006), 260–263.
21. [21] Mangiavacchi, M., Gasparini, M., Faletra, F., Klersy, C., Morenghi, E., Galimberti, P., Genovese, L., Regoli, F., De Chiara, F., Bragato, R., Andreuzzi, B., Pini, D., Gronda, E., Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure. Am. Heart J., 151, 2006, 477 (e1–477.e6).
22. [22] Goldenberg, I., Moss, A.J., Hall, W.J., Foster, E., Goldberger, J.J., Santucci, P., Shinn, T., Solomon, S., Steinberg, J.S., Wilber, D., Barsheshet, A., McNitt, S., Zareba, W., Klein, H., MADIT-CRT executive committee. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 124 (2011), 1527–1536.
23. [23] Cleland, J.G., Tageldien, A., Buga, L., Wong, K., Gorcsan, J. 3rd., Should we be trying to define responders to cardiac resynchronization therapy?. JACC Cardiovasc. Imaging 3 (2010), 541–549.
24. [24] Yu, C.M., Bleeker, G.B., Fung, J.W., Schalij, M.J., Zhang, Q., van der Wall, E.E., Chan, Y.S., Kong, S.L., Bax, J.J., Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005), 1580–1586.
25. [25] Park, J.H., Negishi, K., Grimm, R.A., Popovic, Z., Stanton, T., Wilkoff, B.L., Marwick, T.H., Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events. Circ. Cardiovasc. Imaging 6 (2013), 864–872.
26. [26] Reiter, R.J., Manchester, L.C., Fuentes-Broto, L., Tan, D.X., Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J. Hypertens. 28:Suppl. 1 (2010), S7–S12.
27. [27] Paulis, L., Pechanova, O., Zicha, J., Krajcirovicova, K., Barta, A., Pelouch, V., Adamcova, M., Simko, F., Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats. J. Hypertens. Suppl. 27 (2009), S11–S16.
28. [28] Chrysohoou, C., Kotroyiannis, I., Antoniou, C.C., Brili, S., Vaina, S., Latsios, G., Tousoulis, D., Pitsavos, C., Stefanadis, C., Left atrial function predicts heart failure events in patients with newly diagnosed left ventricular systolic heart failure during short-term follow-up. Angiology 65 (2014), 817–823.
29. [29] Martin, D.T., McNitt, S., Nesto, R.W., Rutter, M.K., Moss, A.J., Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT). Circ. Heart Fail. 4 (2011), 332–338.